1. Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis;Singh;J Rheumatol,2003
2. Use of prescription medications that potentially interfere with blood pressure control in new-onset hypertension and treatment-resistant hypertension;Hwang;Am J Hypertens,2018
3. Kitov Pharma Ltd. Study to evaluate the effect of celecoxib on the efficacy and safety of amlodipine in subjects with hypertension requiring antihypertensive therapy. Available at: https://clinicaltrials.gov/ct2/show/results/NCT02172040. NLM identifier: NCT02172040. 2017. Accessed August 23, 2018.
4. Kitov Pharmaceuticals. Corporate presentation. Available at: http://kitovpharma.investorroom.com/download/KitovPresentation-March2018.pdf. Published March, 2018. Accessed August 23, 2018.
5. Burrell I. Kitov is trailblazer in combined treatment for osteoarthritis and hypertension. Available at: https://www.bloomberg.com/news/sponsors/kitov-pharmaceuticals/kitov-is-trailblazer-in-combined-treatment-for-osteoarthritis-and-hypertension/?adv=17613&prx_t=4LcDAx5ghAVUANA. Published June 18, 2018. Accessed August 23, 2018.